New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

September 2021

Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust and long-lived humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in both young and aging mice.

Read more at News-Medical.Net here.

Read more at biorXiv here.